Gamma subunit of complement component 8 is a neuroinflammation inhibitor

Gamma subunit of complement component 8 is a neuroinflammation inhibitor

DownLoad

The complement system is part of the innate immune system that comprises several small proteins activated by sequential cleavages. The majority of these complement components, such as components 3a (C3a) and C5a, are chemotactic and pro-inflammatory. However, in this study, we revealed an inhibitory role of complement component 8 gamma (C8G) in neuroinflammation. In patients with Alzheimer's disease, who exhibit strong neuroinflammation, we found higher C8G levels in brain tissue, CSF, and plasma. Our novel findings also showed that the expression level of C8G increases in the inflamed mouse brain, and that C8G is mainly localized to brain astrocytes. Experiments using recombinant C8G protein and shRNA-mediated knockdown showed that C8G inhibits glial hyperactivation, neuroinflammation, and cognitive decline in acute and chronic animal models of Alzheimer's disease. Additionally, we identified sphingosine-1-phosphate receptor 2 (S1PR2) as a novel interaction protein of C8G and demonstrated that astrocyte-derived C8G interacts with S1PR2 to antagonize the pro-inflammatory action of S1P in microglia. Taken together, our results reveal the previously unrecognized role of C8G as a neuroinflammation inhibitor. Our findings pave the way towards therapeutic containment of neuroinflammation in Alzheimer's disease and related neurological diseases.
Keywords: astrocytes; complement component 8 gamma; microglia; neuroinflammation; sphingosine-1-phosphate receptor 2.

Reference
Kim, J. H., Afridi, R., Han, J., Jung, H. G., Kim, S. C., Hwang, E. M., ... & Suk, K. (2021). Gamma subunit of complement component 8 is a neuroinflammation inhibitor. Brain, 144(2), 528-552.

• Activation of the Complement System by Urban Particulate Matter
• Adipsin Is a Potential Predictor for Preeclampsia in Early Pregnancy
• Alternative C3 Complement System: Lipids and Atherosclerosis
• Antimicrobial Peptide as Complement System Modulator
• ARGX-117, a therapeutic complement inhibiting antibody targeting C2
• Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients
• C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus
• Cerebrospinal fluid complement system biomarkers in demyelinating disease
• Coagulation Complement Activation and Cerebral Hypoperfusion
• Complement Activation in the Central Nervous System
• Complement Activation in the Disease Course of Coronavirus Disease 2019
• Complement Pathway Activation Is Associated With COVID-19 Mortality
• Complement as the enabler of carfilzomib-induced thrombotic microangiopathy
• Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Subjects
• Complement component C4 levels in the cerebrospinal fluid and plasma of patients
• Complement DAF is a modulator of influenza A virus lung immunopathology
• Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a
• Danicopan an oral CFD inhibitor for paroxysmal nocturnal hemoglobinuria
• Dendrimer end-terminal motif-dependent evasion of complement activation
• Endothelial C3a receptor mediates vascular inflammation and BBB permeability
• Genetic and molecular evidence for complement dysregulation in patients
• Inhibition of complement C5a receptor protects lung cells and tissues
• Interference of the Zika Virus E-Protein With the MAC of the Complement System
• Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
• Microglial trogocytosis and the complement system regulate axonal pruning in vivo
• Modulation of complement activation by pentraxin-3 in prostate cancer
• Monitoring of the Complement System Status in Patients
• Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5
• Overexpression of C4A promotes excessive synaptic loss and behavioral changes
• Quantitative multiplex profiling of the complement system to diagnose diseases
• REV-ERBα mediates complement expression and diurnal regulation of phagocytosis
• SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
• Specific Evolution and Gene Family Expansion of C3 and Regulatory CFH in Fish
• Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling
• Synaptic and complement markers in extracellular vesicles in multiple sclerosis
• The allosteric modulation of complement C5 by knob domain peptides
• The complement system drives local inflammatory tissue priming
• The solution structure of the complement deregulator FHR5 reveals a compact dimer
• Two human antibodies enhance binding of CFH by stabilizing the CFH binding site